Related by context. All words. (Click for frequent words.) 74 breast endometrial 73 ovarian breast 73 uterine ovarian 73 pancreatic prostate 73 ovarian lung 72 endometrial cancers 72 colorectal lung 72 breast pancreatic 70 pancreatic lung 70 ovarian pancreatic 70 testicular germ cell 69 prostate colon 69 leukemia multiple myeloma 69 Basal cell 69 pancreatic ovarian 69 breast ovarian 68 colorectal pancreatic 68 pancreatic colon 68 prostate bladder 68 basal cell carcinoma squamous 68 carry BRCA mutation 68 LHRH receptor positive 68 ductal breast cancer 67 gastrointestinal cancers 67 testicular cancers 67 cervical breast 67 breast uterine 67 hormone refractory prostate 67 ovarian colon 67 osteosarcomas 67 CYT# potent vascular disrupting 67 gastric pancreatic 67 epithelial cancers 67 bladder cancers 67 hormone receptor negative 67 lymphomas leukemias 67 endometriosis ovarian cysts 66 atypical hyperplasia 66 lung pancreatic 66 Squamous cell 66 pancreatic gastric 66 Colon polyps 66 precursor lesions 66 colorectal prostate 66 nodal metastasis 66 gastric cancers 66 breast ovary 66 lobular carcinoma 66 neuroendocrine cancers 66 colorectal gastric 65 bladder ovarian 65 pancreatic adenocarcinoma 65 metastatic colorectal 65 deCODE ProstateCancer TM 65 hematological disorders 65 squamous cell carcinoma SCC 65 lung ovary 65 metastatic pancreatic 65 metastatic prostate 65 Alessandro Riva 65 dysplastic lesions caused 65 basal cell carcinoma BCC 65 lung colorectal 65 castrate resistant prostate cancer 65 faulty BRCA2 gene 65 lobular breast cancer 65 colon pancreas 64 epithelial tumors 64 skeletal metastases 64 colon breast 64 leukaemias 64 Squamous 64 lung prostate 64 prostate lung 64 HNSCC 64 kidney urologic 64 invasive ductal 64 nasopharyngeal carcinoma 64 Carcinoid tumors 64 myeloproliferative neoplasms 64 cirrhosis liver failure 64 Carcinomas 64 bladder prostate 64 lymphoproliferative disorders 64 prostate ovarian 64 prostate cancer CaP 64 oligodendrogliomas 64 castration resistant hormone refractory 64 precancerous cervical 64 colon prostate 64 BRCA2 mutations 64 Menopausal hormone therapy 64 ovarian uterine 64 ovarian prostate 64 leukemia AML 63 HLA DR 63 Basal Cell 63 malignancies 63 prostate carcinoma 63 colorectal carcinoma 63 castrate resistant 63 endometrial ovarian 63 colorectal breast 63 HPV vaccine protects 63 lung colon 63 chronically immunosuppressed solid 63 colorectum 63 resistant hormone refractory 63 cisplatin resistant 63 prostate colorectal 63 prostate breast 63 colorectal bladder 63 gastric carcinoma 63 adenocarcinomas 63 HER2 positive cancers 63 prostate testicular 63 recurrent NSCLC 63 GISTs 63 Uterine cancer 63 metastatic gastric 63 invasive lobular 63 endometrial carcinoma 63 ovary uterus 63 ovarian endometrial 63 metachronous 63 seminoma 63 Vidaza ® 63 Sezary syndrome 63 pancreatic bladder 63 K ras mutations 63 BRCA2 carriers 63 ovarian colorectal 63 leiomyomas 63 overt hepatic encephalopathy HE 63 lymphoid tumors 63 anal cancers 63 nonmelanoma skin cancers 63 metastatic bladder 63 neoplasias 63 deCODE BreastCancer 63 endometrial breast 63 ErbB2 positive 63 Cholangiocarcinoma 63 T1c 63 penile anal 63 myeloproliferative disorders 63 advanced adenomas 63 lymph node enlargement 63 esophageal cancers 63 gastrointestinal stromal tumors GISTs 62 colorectal cancer CRC 62 intestinal polyps 62 BRCA1 mutations 62 benign breast 62 progesterone receptor negative 62 parathyroid carcinoma 62 leukemia myeloma 62 alpha1 antitrypsin AAT deficiency 62 Ovary removal 62 situ CIS 62 hormone deprivation 62 chronic periodontitis 62 metastatic androgen independent 62 pulmonary metastases 62 cervical carcinoma 62 cancers 62 serous ovarian cancer 62 renal cell carcinomas 62 grade serous ovarian 62 leukemias lymphomas 62 male hormones androgens 62 recurrent ovarian 62 androgen independent 62 hormonally responsive 62 squamous cell cancers 62 endometrial hyperplasia 62 refractory anemia RA 62 refractory metastatic 62 solar keratosis 62 subependymal giant cell 62 Leukemias 62 TTR amyloidosis 62 papillary renal cell carcinoma 62 radiation chemoradiation 62 Solazed TM 62 basal cell cancers 62 Erythropoietic therapies may 62 prostate cancer CRPC 62 hormonally sensitive 62 BRCA1 BRCA2 62 hematopoietic malignancies 62 poorer prognosis 62 situ LCIS 62 Uterine fibroids 62 pancreatic colorectal 62 castration resistant 62 Radical prostatectomy 62 penile cancers 62 unresectable tumors 62 tumor xenograft models 62 pancreas colon 62 Benign prostatic hyperplasia BPH 61 BRCA2 gene mutations 61 colon ovarian 61 rheumatoid arthritis lupus 61 lymphomas 61 Acute lymphoblastic leukemia 61 cervical prostate 61 malignant ovarian 61 squamous cell 61 gastrointestinal stromal 61 colorectal ovarian 61 neuroblastomas 61 Vicinium TM 61 Squamous cell carcinomas 61 epithelial ovarian 61 sickle cell cystic fibrosis 61 node metastases 61 cervix colon 61 mutated BRAF gene 61 myelofibrosis polycythemia vera 61 lymphoma Hodgkin lymphoma 61 obese postmenopausal 61 TRAIL R1 61 receiving chemoradiation therapy 61 pancreas esophagus 61 muscular dystrophy cystic fibrosis 61 TNF blocker therapy 61 HBeAg negative 61 hematological diseases 61 anal penile 61 androgen deficiency 61 lung esophageal 61 hyperplasia BPH 61 Hurthle cell 61 Metastases 61 antiangiogenesis therapies 61 esophagus bladder 61 oesophageal adenocarcinoma 61 pediatric malignancies 61 breast colon 61 CTAP# Capsules 61 KRAS oncogene 61 diffuse gastric 61 BRCA2 mutation 61 grade squamous intraepithelial 61 melanoma basal cell 61 elevated triglyceride levels 61 adrenocortical cancer 61 lung carcinomas 61 benign neoplasms 61 BMPR2 61 fibroids endometriosis 61 skeletal muscle weakness 61 cause cardiac channelopathies 61 hormone therapy estrogen 61 faulty BRCA genes 61 HER2 positive metastatic breast 61 ductal cancer 61 peritoneal carcinomatosis 61 essential thrombocythemia ET 61 vulvar vaginal 61 commercialize deforolimus 61 cervical ovarian 61 rates Tangka 61 onset diabetes mellitus 61 grade gliomas 61 molecular abnormalities 61 ovarian cervical 61 neoplasia 61 HER2 positive breast 61 ABCB1 61 MYCN amplification 61 premalignant 60 Hepatocellular 60 histologies 60 premalignant lesion 60 chronic eosinophilic leukemia 60 mutated BRCA1 60 Elevated PSA 60 tamoxifen Nolvadex ® 60 seminomas 60 transferrin saturation 60 cyclin E 60 cervical dysplasia 60 breast carcinoma 60 urothelial carcinoma 60 uterine tumors 60 abnormal pap smears 60 aerodigestive tract 60 nonmetastatic 60 TT genotype 60 nonsmall cell lung cancer 60 bladder colon 60 LRP5 60 Li Fraumeni 60 cervical intraepithelial neoplasia 60 commonly mutated genes 60 lung adenocarcinoma 60 cardiovascular disease hypertension 60 TGFBR1 * 6A 60 neovascular diseases 60 immunodeficiency disorders 60 anaplastic 60 lung ovarian 60 elevated CRP 60 secondary hyperparathyroidism 60 obstructive coronary 60 Metastatic 60 BRCA1 mutation carriers 60 prostate adenocarcinoma 60 p# mutations 60 CIN3 60 differentiated thyroid 60 cardio metabolic diseases 60 metastatic renal 60 Androgen deprivation therapy 60 non resectable metastatic 60 Leydig cell 60 ribonucleotide reductase clinically validated 60 C. trachomatis 60 pheochromocytoma 60 colorectal adenoma 60 contralateral breast 60 lymphoma subtypes 60 Malignant Melanoma 60 pelvic malignancies 60 lobular cancer 60 malignant lymphoma 60 oncogenic HPV 60 MYH9 gene 60 gastric adenocarcinoma 60 ovarian carcinoma 60 prostate cancers 60 multiple sclerosis psoriasis 60 ovarian tumors 60 colon pancreatic 60 smoldering myeloma 60 Raf MEK ERK 60 rheumatoid arthritis juvenile idiopathic 60 PCA3 scores 60 bladder cervix 60 lenalidomide Revlimid R 60 premalignant lesions 60 System IPSS 60 ADPKD 60 HER2 receptor 60 histologic subtype 60 tumor metastases 60 esophagus colon 60 gefitinib Iressa 60 Acute myelogenous leukemia 60 gastric cardia 60 pAkt 60 inflammatory autoimmune diseases 60 testicular prostate 60 Kit CD# positive 60 dysplastic nevi 60 hypereosinophilic syndrome 60 Provectus Pharmaceuticals specializes 60 basal cell skin 60 malignant prostate 60 nonalcoholic steatohepatitis 60 gynecologic malignancy 60 HPVs 60 chromosomal disorders 59 imatinib Gleevec 59 nonmelanoma 59 eccrine 59 systemic juvenile idiopathic 59 astrocytomas 59 vaginal lesions 59 myelomas 59 breast colorectal 59 glioma rarer 59 AstraZeneca Arimidex 59 genital tract infections 59 proliferative diseases 59 Soft Tissue Sarcoma 59 squamous cell skin 59 erythematosus 59 FGFR2 59 recurrent ovarian cancer 59 uterine cervical 59 cervical neoplasia 59 KIF6 gene 59 estrogen receptor negative 59 locoregional recurrence 59 rheumatoid arthritis multiple sclerosis 59 keloid scarring 59 hereditary predisposition 59 squamous cell lung cancer 59 intra arterial chemotherapy 59 nonalcoholic steatohepatitis NASH 59 Proxinium TM 59 grade cervical intraepithelial 59 rheumatoid arthritis systemic lupus 59 metastatic malignant 59 Glioblastoma multiforme GBM 59 neoplasia PIN 59 leukemia lymphomas 59 sPLA2 59 basal cell nevus syndrome 59 urethritis 59 Gliomas 59 malignant neoplasm 59 Androgenetic Alopecia 59 syngeneic 59 alkylating agents 59 haematologic 59 antiproliferative effects 59 androgens male 59 neurofibromas 59 bowel cancers 59 Adjuvant chemotherapy 59 BRAF mutated 59 Melanomas 59 prostatic hyperplasia 59 myeloproliferative diseases 59 hepatocellular carcinoma liver 59 Endometrial cancer 59 endometrial kidney 59 fibrocystic disease 59 Low Testosterone 59 HIV HCV coinfected 59 pre cancerous growths 59 promoter hypermethylation 59 carotid plaques 59 relapsed leukemia 59 squamous cell carcinomas 59 lupus scleroderma 59 deCODE BreastCancer TM 59 AML MDS 59 carcinoma HCC 59 papillary 59 BRCA gene mutation 59 hormone refractory metastatic prostate 59 systemic autoimmune 59 Colorectal cancer CRC 59 sarcomatoid 59 PTEN mutations 59 Benign breast 59 cell acute lymphoblastic 59 BRCA mutations 59 HER2 positive tumors 59 axillary lymph nodes 59 onset idiopathic hypogonadism 59 EGFR HER2 59 untreated metastatic pancreatic 59 MTHFR 59 recurrent metastatic 59 hormonal therapies 59 incontinence erectile dysfunction 59 myeloid leukemia 59 pancreatic cancers 59 Chlamydia trachomatis infection 59 hematologic disorders 59 ductal carcinomas 59 lung cancer NSCLC 59 basal cell cancer 59 tumors GIST 59 CIN2 + 59 diseases fat malabsorption 59 prostate abnormalities 59 Testicular cancer 59 familial pancreatic cancer 59 urothelial bladder cancer 59 metastatic liver 59 IL 1Ra 59 anogenital 59 advanced epithelial ovarian 59 colorectal liver 59 tumor xenografts 59 advanced hepatocellular carcinoma 59 eIF 4E 59 leukemia ALL 59 untreated celiac disease 59 metastatic neuroendocrine tumors 59 Evoltra ® 59 cystic fibrosis muscular dystrophy 59 Shark cartilage 59 lipid abnormalities 59 Nonalcoholic fatty liver 59 acute leukemias 59 hyperphenylalaninemia HPA due 59 anemia neutropenia 59 gastrointestinal malignancies 59 AAT deficiency 59 cervical uterine 59 basal cell 59 Hashimoto thyroiditis 59 precancerous tumors 59 uterine cervix 59 CVD mortality 59 prostate TURP 59 cervix uteri 59 nonseminoma 59 asthma rhinitis 59 lung cancer asbestosis 59 thyrotropin 59 atrophic gastritis 59 endometrial cancer 59 chlamydial infection 59 colorectal tumors 59 bone metastasis 59 thrombo embolic 59 coagulation disorders 59 carcinomas 59 Human papillomavirus 59 renal tumors 59 Tay Sachs thalassemia 59 operable breast cancer 59 BRCA2 gene mutation 59 IDH mutations 59 multiple sclerosis rheumatoid arthritis 59 papillomaviruses 59 chromosomal rearrangement 59 endocrine tumors 59 CHD CVD 59 oral squamous cell 59 myelodysplastic syndromes MDS 59 HER2 amplified 59 ovarian carcinomas 59 mucinous 59 pediatric acute lymphoblastic 59 mycosis fungoides 59 relapsed ALL 59 relapsed acute lymphoblastic 59 superficial basal cell carcinoma 59 carcinoid 59 Smac mimetic 59 External Sensitivity Risk 59 rs# [001] 59 CCR9 antagonist 58 hepatocellular cancer 58 Pancreatic neuroendocrine tumors 58 Epidermal Growth Factor Receptor 58 xenograft models 58 metastatic HER2 positive 58 Glioblastomas 58 lobular carcinomas 58 polycystic ovarian syndrome PCOS 58 liver cancers hypercholesterolemia 58 NMIBC 58 GSTP1 58 Soft tissue sarcomas 58 sodium thiosulfate STS 58 Chronic lymphocytic leukemia 58 frequently benign tumor 58 dasatinib Sprycel 58 lymphoma myeloma 58 BRCA deficient 58 MEK inhibitors 58 neoplasms 58 mtDNA mutations 58 Chronic lymphocytic leukemia CLL 58 lung adenocarcinomas 58 squamous cell cancer 58 hematopoietic cancers 58 LungAlert TM 58 refractory chronic lymphocytic 58 androgen deprivation 58 esophageal squamous cell carcinoma 58 leiomyoma 58 esophageal adenocarcinoma 58 trastuzumab Herceptin ® 58 ovarian cancers 58 novel VDA molecule 58 Thyroid nodules 58 Her2 positive 58 intestinal metaplasia 58 invasive carcinoma 58 malignant fibrous histiocytoma 58 advanced adenoma 58 breast cancer subtypes 58 thalassemia sickle cell 58 colon tumors 58 Alzheimer disease vascular dementia 58 myelodysplastic syndrome MDS 58 lupus erythematosus 58 cervical lesions 58 circulating estrogens 58 Factor Receptor 58 fibroadenomas 58 medically inoperable 58 cell carcinomas 58 chronic lymphocytic 58 hepatocellular 58 III EGFRvIII 58 Androgens 58 oropharyngeal cancer 58 CDH1 58 C#Y 58 neoplastic 58 tuberous sclerosis TS 58 prognostic markers 58 cutaneous melanoma 58 lymphoid malignancies 58 vascular disorders 58 monocyte chemoattractant protein 58 finasteride Proscar 58 diabetes hyperlipidemia 58 chemotherapy induced neutropenia 58 B7 H3 58 MCF7 58 treating sarcoma testicular 58 proctitis 58 thromboembolic disease 58 arterial calcification 58 keloid scarring treatment 58 accumulate preferentially 58 FLT3 58 Invasive Breast Cancer 58 BRAF mutant 58 PCa 58 GSTT1 58 uterine cancers 58 AVODART 58 prostate carcinomas 58 anti angiogenic agents 58 Squamous cell cancer 58 TTR gene 58 basal cell carcinomas 58 malignant brain 58 benign prostatic hypertrophy 58 chemo resistant 58 Prostatitis 58 undergoing radical prostatectomy 58 myopathies 58 lobular 58 EGFR mutant 58 tumor histology 58 hyperplastic 58 non polyposis colorectal 58 liver metastasis 58 Postmenopausal 58 colon rectum breast 58 precancers 58 relapsed MM 58 metastatic castrate resistant 58 rheumatoid arthritis inflammatory bowel 58 malignant pancreatic 58 degenerative neurological diseases 58 reproductive abnormalities 58 Metastatic Prostate Cancer 58 soft tissue sarcomas 58 imatinib Gleevec ® 58 protein kinase inhibitors 58 hamartomas 58 Systemic lupus erythematosus 58 pulmonary metastasis 58 haematopoietic stem cell 58 Zyclara Cream 58 gastric atrophy 58 cervix vagina 58 Synovial sarcoma 58 vaginal cancers 58 JAK inhibitors 58 liver cancers TTR 58 Li Fraumeni Syndrome 58 CC genotype 58 Papillary 58 hypermethylated 58 abdominal adiposity 58 LymphoStat B belimumab 58 specific antigen PSA 58 cerebrovascular diseases 58 Ribavirin causes 58 myelogenous leukemia 58 chromosomal anomalies 58 hypovitaminosis D 58 Teverelix 58 Genetic variants 58 chills fever headache 58 esophageal tumors 58 chemotherapy cisplatin 58 clinically localized prostate 58 androgen receptor antagonist 58 KRAS mutations 58 colon esophageal 58 cervical vulvar 58 telomere lengths 58 tongue mouth pharynx 58 HuLuc# 58 methylation markers 58 intravenous bisphosphonates 58 taxane therapy 58 cystic fibrosis chronic pancreatitis 58 advanced metastatic prostate 58 HER2 overexpression 58 normal karyotype 58 endocrine therapies 58 microvascular disease 58 Relapsed Refractory 58 Squamous Cell 58 Adenomas 58 nonmelanoma skin cancer 58 familial amyloidotic polyneuropathy FAP 58 lymphoma leukemia 58 monoclonal antibody therapies 58 1 diabetes T1D 58 colorectal polyps 58 neoplastic diseases 58 androgen dependent 58 Malignancies 58 Cutaneous T 58 bacterial prostatitis 58 delta isoform 58 breast cancer metastasis 58 pancreatic endocrine 58 Previously Untreated 58 Ovarian cysts 58 T1DM 58 CD# expressing 58 leukemia lymphoma multiple myeloma 58 vaginal candidiasis 58 histological subtype 58 lymphoid organs 58 p# mutation 58 GnRH agonists 58 metastatic castration resistant 58 causes genital warts 58 JNK pathway 58 hepatocellular carcinomas 58 anal lesions 58 osteopenic 58 neuroblastoma tumors 58 metaplasia 58 Epstein Barr virus EBV 57 postmenopausal breast cancer 57 cancer mCRC 57 fibrocystic 57 Trichomonas vaginalis 57 polycystic ovarian disease 57 bone marrow lymph nodes 57 abnormal pap tests 57 tumor subtype 57 atypical ductal hyperplasia 57 antiangiogenic agents 57 severe malignant osteopetrosis 57 xenograft tumors 57 fatal IHD 57 rheumatoid arthritis thrombocytopenia 57 Aromatase inhibitors 57 elevated triglycerides 57 fallopian tube carcinoma 57 Smac mimetics 57 gastrointestinal mucositis 57 bilateral oophorectomy 57 distal colon cancer 57 raloxifene Evista 57 paragangliomas 57 rheumatoid arthritis psoriasis 57 HER2 ErbB2 57 MAbs targeting 57 mediated autoimmune diseases 57 Darapladib 57 CCR5 delta# 57 RET PTC rearrangements 57 erlotinib Tarceva ® 57 cervical lymph nodes 57 Inflammatory bowel diseases 57 malignant pleural mesothelioma 57 oophorectomy 57 elevated LDL cholesterol 57 Hypogonadism 57 proliferative retinopathy 57 squamous 57 antiestrogen 57 beta blockers ACE inhibitors 57 Carcinoma 57 serum prostate 57 cell lymphoma CTCL 57 mental retardation epilepsy 57 NSAID associated 57 minimally symptomatic 57 Lymphomas 57 Chronic Myelogenous Leukemia CML 57 rhabdoid 57 gemcitabine Gemzar 57 anthracycline taxane 57 Parkinson disease multiple sclerosis 57 Gorlin syndrome 57 myelodysplastic myeloproliferative diseases 57 Colorectal cancers 57 testicular tumors 57 juvenile idiopathic arthritis JIA 57 tumor subtypes 57 colorectal 57 anemias 57 alpha1 antitrypsin deficiency 57 papillomas 57 International Prognostic Scoring 57 fungoides 57 commonest cancers 57 invasive ductal carcinomas 57 Gleevec resistant 57 GVAX Immunotherapy 57 neoplastic lesions 57 delay bone metastases 57 hemoglobinopathies 57 esophagus pancreas 57 apocrine 57 PLX STROKE targeting 57 neurologic complications 57 Delta opioid receptor 57 cervical vaginal 57 hormone gastrin 57 spinal metastases 57 multiforme 57 acid phosphatase PAP 57 cMET 57 antimitotic 57 benign prostatic hyperplasia enlarged 57 cause mesothelioma asbestosis 57 acute humoral rejection 57 precancerous cervical lesions 57 cryptococcosis 57 advanced medullary thyroid 57 NSAID induced GI 57 slow metabolizers 57 plus dacarbazine 57 cancerdefine 57 distant metastasis 57 oesophageal cancers 57 gene BRCA2 57 Human papillomaviruses 57 undergone radical prostatectomy 57 benign prostatic hypertrophy BPH 57 FGFR2 gene 57 transplantation HCT 57 epithelial ovarian cancer 57 hepatocellular carcinoma HCC 57 abnormal growths 57 PCNSL 57 Idiopathic pulmonary fibrosis 57 colorectal cancers 57 orchitis 57 B Cell Lymphoma 57 Androgenetic alopecia 57 hormone refractory 57 Androgen Deprivation Therapy 57 subclinical disease 57 Adjuvant Chemotherapy 57 adenomatous polyp 57 Myelofibrosis 57 autoantibody positive 57 nodular melanoma 57 proximal colon 57 PIK3CA 57 recurrent glioblastoma 57 Folic acid supplements 57 Hodgkin lymphoma HL 57 prostate cancer PCa 57 immunotherapeutic approaches 57 pancreatic islet cell 57 antisense inhibition 57 CYP#A# CYP#D# 57 non alcoholic steatohepatitis 57 immunodeficiencies 57 Bone metastases 57 chronic myeloid 57 signal transduction inhibitors 57 cancerous enlargement 57 germline mutations 57 psoriasis rheumatoid arthritis 57 chronic prostatitis 57 Squamous Cell Carcinoma 57 BRCA mutation carriers 57 breast cervical 57 hereditary hemochromatosis 57 androgen receptor AR 57 immunocompetent 57 leukemia CLL 57 alpha interferons 57 HGPIN 57 recurrent DVT 57 undescended testicles 57 hepatic renal 57 neck squamous cell 57 Advanced Prostate Cancer 57 abnormal lipid 57 hypervascular tumors 57 intracranial atherosclerosis 57 gastro intestinal inflammation 57 histologically confirmed 57 Hormone pills 57 benign noncancerous 57 vulvar cancers 57 Nilotinib 57 metastatic ocular 57 antiplatelet medications 57 Clusterin 57 Chlamydia infection 57 OVARIAN 57 Kaposi sarcoma 57 A3 adenosine receptor 57 Radiographic findings 57 TNF alpha antagonist 57 dermatologic reactions 57 stage IIIB 57 preclinical xenograft models 57 Adenocarcinoma 57 SSc 57 colorectal polyp 57 subclinical hyperthyroidism 57 anaplastic astrocytomas 57 Hepatocellular Carcinoma HCC 57 hCG beta 57 Rectal cancer 57 Human papilloma virus 57 alpha folate receptor 57 Drug Prevents 57 cutaneous squamous cell carcinoma 57 ZACTIMA TM ZD# 57 hematologic malignancies 57 thyrotropin levels 57 Acute leukemia 57 symptomatic fibroids 57 pituitary tumors 57 lupus multiple sclerosis 57 novel tubulin binding 57 haematologic malignancies 57 keloids 57 decompensated liver disease 57 Chronic myeloid leukemia CML 57 Philadelphia Chromosome Positive 57 colorectal neoplasms 57 BRAF V#E 57 benign moles 57 localized prostate 57 treating cancerous tumors 57 prednisone prednisolone 57 hepatocellular carcinoma 57 Epstein Barr Virus EBV 57 immuno inflammatory diseases 57 gestational hypertension 57 Acute myeloid leukemia AML 57 infectious diseases autoimmune diseases 57 metastatic malignant melanoma 57 LHRH analogues 57 hypercalcemia 57 Malignant tumors 56 uveal melanoma 56 abnormal glucose tolerance 56 angiogenic responses 56 vinca alkaloids 56 curable cancers 56 meningiomas 56 radiofrequency ablation RFA 56 benign growths 56 prostate carcinogenesis 56 Cardiotoxicity 56 systemic lupus erythematosus 56 severe hepatic dysfunction 56 exemestane Aromasin 56 gastric carcinogenesis 56 pleural mesothelioma 56 Cell Non Hodgkin 56 Endometrial 56 deep venous thromboses 56 simplex virus 56 hematologic cancers 56 C1 INH deficiency 56 prostate radical prostatectomy 56 Sjögren syndrome 56 Human papillomavirus HPV 56 interleukin IL -# 56 Basal cell carcinoma 56 cell lymphomas 56 intraepithelial neoplasia 56 ANCA associated 56 thromboembolic complications 56 emphysema chronic bronchitis 56 myeloid 56 metastatic adenocarcinoma 56 precancerous condition 56 polycystic ovary syndrome PCOS 56 Thalomid ® 56 depsipeptide 56 elevated hsCRP 56 HER2 expression 56 indolent follicular non 56 hormonal abnormalities 56 acute myelogenous leukemia AML 56 rheumatic disease 56 anticoagulants blood thinners 56 venous thromboembolic events 56 lymphocytic leukemia 56 medullary thyroid cancer 56 Zolinza 56 chemopreventive agents 56 Chronic HCV 56 Skin Cancers 56 pituitary adenomas 56 salpingo oophorectomy 56 postoperative chemotherapy 56 glioblastoma tumor 56 hematopoietic cell